Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach
一项针对胃食管交界处或胃腺癌患者的II期临床试验，评估硼替佐米单药或联合伊立替康的疗效。
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-014-0070-0
Ocean, Allyson J; Christos, Paul; Sparano, Joseph A; Shah, Manish A; Yantiss, Rhonda K; Cheng, Jonathan; Lin, Juan; Papetti, Michael; Matulich, Dan; Schnoll-Sussman, Felice; Besanceney-Webler, Christen; Xiang, Jenny; Ward, Maureen; Dilts, Kaili Temple; Keresztes, Roger; Holloway, Shannon; Chen, Eric X; Wright, John J; Lane, Maureen E
